Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 596.85 INR 1.73% Market Closed
Market Cap: 144.7B INR
Have any thoughts about
Granules India Ltd?
Write Note

Granules India Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Granules India Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Granules India Ltd
NSE:GRANULES
Pre-Tax Income
â‚ą6.6B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
17%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Pre-Tax Income
â‚ą72.3B
CAGR 3-Years
35%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Pre-Tax Income
â‚ą61.3B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Pre-Tax Income
â‚ą128.4B
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Pre-Tax Income
â‚ą25.8B
CAGR 3-Years
15%
CAGR 5-Years
30%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Pre-Tax Income
â‚ą24B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Granules India Ltd
Glance View

Market Cap
144.7B INR
Industry
Pharmaceuticals

In the bustling corridors of the pharmaceutical world, Granules India Ltd. has carved out a distinctive niche through its unwavering commitment to efficiencies and economies of scale. Founded in 1984, the company began its journey as an operator of a small Paracetamol facility and steadily evolved into a formidable player on the global stage. Granules India's business model is streamlined; it meticulously integrates its manufacturing processes, focusing primarily on Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosage Forms (FDFs). By leveraging vertically integrated operations, the company ensures a seamless transition from raw material to finished product, reducing costs while maintaining high standards of product quality, an achievement that distinguishes it in the competitive landscape. Granules India capitalizes on its robust manufacturing infrastructure, which operates round the clock to serve a diverse clientele spanning across regulated and semi-regulated markets. This emphasis on cost-effective production is coupled with strategic geographical placement of its facilities, allowing it to cater efficiently to domestic and international markets, including North America, Europe, and emerging economies. The company's revenue streams are largely driven by the sales of its extensive product portfolio, which includes key therapeutic areas like over-the-counter (OTC) brands and prescription medications. By maintaining a diversified product line and emphasizing high-volume, low-margin products, Granules India continually fortifies its market position while sustaining a healthy balance between growth and stability.

GRANULES Intrinsic Value
456.52 INR
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Granules India Ltd's Pre-Tax Income?
Pre-Tax Income
6.6B INR

Based on the financial report for Sep 30, 2024, Granules India Ltd's Pre-Tax Income amounts to 6.6B INR.

What is Granules India Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
17%

Over the last year, the Pre-Tax Income growth was 23%. The average annual Pre-Tax Income growth rates for Granules India Ltd have been 2% over the past three years , 11% over the past five years , and 17% over the past ten years .

Back to Top